Literature DB >> 24199622

Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2.

Meryl Brod1, Michael Wolden, Danielle Groleau, Donald M Bushnell.   

Abstract

OBJECTIVE: To examine the daily functioning, diabetes management, and economic burden of non-severe nocturnal hypoglycemic events (NSNHEs) in Canada and differences in impacts by diabetes type. RESEARCH DESIGN AND METHODS: A 20-min web-based survey, with items derived from the literature, expert and patient interviews, assessing the impact of NSNHEs, was administered to patients with self-reported diabetes aged ≥18 having an NSNHE in the past month.
RESULTS: Two thousand, two hundred and seventy-nine Canadian persons with diabetes were screened with 200 respondents meeting criteria and included in the analysis sample. Out of 87 working respondents, 15 reported on average 3.5 h of lost work (absenteeism). The reduction in work productivity (presenteeism) reported was comparable to the impact of arthritis. Other functional impacts included sleep and daily activities. Additionally, respondents' increased their usual blood sugar monitoring practice, on average, 4.2 (SD = 7.5) extra tests were conducted in the week following the event and reduced their insulin over the following 4.8 days. Increased healthcare utilization was also reported. Increased costs as a result of NSNHE for lost work productivity, increased diabetes management, and resource utilization was CAD 70.67 per person per year in this sample. Limitations of the study include the biases which are associated with a web-based survey and self-reported data.
CONCLUSIONS: NSNHEs have serious consequences for patients and diabetes management practices. Greater attention to treatments which reduce NSNHEs can have a major impact on improving functioning while reducing the economic burden of diabetes.

Entities:  

Mesh:

Year:  2013        PMID: 24199622     DOI: 10.3111/13696998.2013.857676

Source DB:  PubMed          Journal:  J Med Econ        ISSN: 1369-6998            Impact factor:   2.448


  10 in total

1.  Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO).

Authors:  Meryl Brod; Lise Højbjerre; Donald M Bushnell; Charlotte Thim Hansen
Journal:  Qual Life Res       Date:  2015-06-21       Impact factor: 4.147

Review 2.  Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.

Authors:  David Rodbard
Journal:  Diabetes Technol Ther       Date:  2017-06       Impact factor: 6.118

3.  Impact of chronic disease self-management programs on type 2 diabetes management in primary care.

Authors:  Samuel N Forjuoh; Marcia G Ory; Luohua Jiang; Ann M Vuong; Jane N Bolin
Journal:  World J Diabetes       Date:  2014-06-15

4.  Perspectives of Patients with Insulin-Treated Type 1 and Type 2 Diabetes on Hypoglycemia: Results of the HAT Observational Study in Central and Eastern European Countries.

Authors:  Martin Haluzik; Adam Kretowski; Krzysztof Strojek; Leszek Czupryniak; Andrej Janez; Peter Kempler; Michal Andel; Tsvetalina Tankova; Mihail Boyanov; Lea Smircic Duvnjak; Laszlo Madacsy; Iwona Tarnowska; Marcin Zychma; Nebojsa Lalic
Journal:  Diabetes Ther       Date:  2018-03-09       Impact factor: 2.945

Review 5.  Nonsevere Hypoglycemia Episode Clinical and Economic Outcomes: A Comparison between Sulfonylurea and Sodium-Glucose Cotransporter 2 Inhibitor as Add-On to Metformin from a Canadian Perspective.

Authors:  Pendar Farahani
Journal:  Int J Endocrinol       Date:  2018-07-08       Impact factor: 3.257

6.  The Incidence of Hypoglycemia among Insulin-Treated Patients with Type 1 or Type 2 Diabetes: Bangladeshi Cohort of International Operations-Hypoglycemia Assessment Tool Study.

Authors:  Md Faruque Pathan; M Fariduddin; Khwaja Nazimuddin; Abdus Saleque Mollah; Md Nazrul Islam Siddiqui; Kazi Ali Hassan; H S Ferdous; Muhammad Hafizur Rahman; S M Ashrafuzzaman; Md Javed Sobhan; Md Reza E-Tanvir Haider; Mohammod Feroz Amin
Journal:  Indian J Endocrinol Metab       Date:  2018 May-Jun

7.  Factors of occurrence and improvement methods of presenteeism attributed to diabetes: A systematic review.

Authors:  Koji Mori; Takahiro Mori; Tomohisa Nagata; Masako Nagata; Mahoko Iwasaki; Hiroki Sakai; Koki Kimura; Natsumi Shinzato
Journal:  J Occup Health       Date:  2019-01       Impact factor: 2.708

8.  Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2.

Authors:  Simon R Heller; J Hans DeVries; Carol Wysham; Charlotte T Hansen; Melissa V Hansen; Brian M Frier
Journal:  Diabetes Obes Metab       Date:  2019-04-15       Impact factor: 6.577

9.  Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes.

Authors:  Thomas Danne; Jeremy Pettus; Andrea Giaccari; Bertrand Cariou; Helena Rodbard; Stuart A Weinzimer; Mireille Bonnemaire; Sangeeta Sawhney; John Stewart; Stella Wang; Rita de Cassia Castro; Satish K Garg
Journal:  Diabetes Technol Ther       Date:  2019-09       Impact factor: 6.118

10.  The Impact of Hypoglycemia on Productivity Loss and Utility in Patients With Type 2 Diabetes Treated With Insulin in Real-world Canadian Practice: Protocol for a Prospective Study.

Authors:  Veronique Lambert-Obry; Jean-Philippe Lafrance; Michelle Savoie; Jean Lachaine
Journal:  JMIR Res Protoc       Date:  2022-03-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.